This website sets cookies which are used to offer a personalized experience on our website, generate statistics, and realize advertising or social network tracking. Find out more about our Privacy & Cookie policy and how to manage them on your browser. You can change your cookie settings at any time.

The Joint CDDW™-CLM Conference 2023 is pleased to announce its Industry Symposium* Schedule taking place on Friday, March 3 and Saturday, March 4.

RSVP now to secure your spot in one of the CDDW™-CLM Specialty Programming or Industry Symposia sessions.

*CDDW-CLM Industry Symposia are unaccredited sessions

Friday, March 3

7:00 - 8:00 CDDW™ INDUSTRY BREAKFAST SYMPOSIUM

Presented by

Title: A Deeper Dive Into the Clinical Implications of Type 2 Inflammation in Eosinophilic Esophagitis and Approaches to Patient Care

Learning Objectives:

  • Examine the underlying type 2 inflammation in EoE pathology and the impact of the progressive nature of the disease on patient burden
  • Review current standard of care in diagnosis and disease management options
  • Evaluate the importance of maintenance therapy in long-treatment of patients with EoE

Speaker: Dr. Natacha Tardio, MD, FRCPC & Dr. Margaret Marcon, MD, FRCPC

Date and Time: Friday, March 3  7:00 - 8:00

Location: Room 501/502

11:30 - 12:30 CDDW™ INDUSTRY LUNCH SYMPOSIUM

Presented by

Title: Unmasking Our Best Practices in IBD: How COVID-19 Shifted the Normal in Patient Care

Learning Objectives:

After attending this session, you will be able to:

  • Explain the importance of a treat-to-target approach and remote/non-invasive monitoring of individuals with IBD, to avoid flares and the use of steroids during the COVID-19 pandemic.
  • Guide and counsel individuals with IBD on the prevention and treatment of COVID-19, and anticipate immune responses to vaccines.
  • Assess the short- and long-term complications of COVID-19 in individuals with IBD, including the risk of long COVID.
  • Discuss the benefits and impact of new methods of care developed and implemented during the COVID-19 pandemic, including telemedicine, remote monitoring and patient self-management.

Speakers: Eric Benchimol, MD, PhD, FRCPC
Gilaad G. Kaplan, MD, MPH, FRCPC, CAGF, AGAF, FCAHS
Cynthia Seow, MBBS(Hons), MSc, FRACP
Laura Targownik, MD, MSHS, FRCPC

Date and Time: Friday, March 3  11:30 - 12:30

Location: Room 501/502

12:15 - 13:00 CanNASH INDUSTRY LUNCH SYMPOSIUM

Presented by

Developed by the CanNASH Steering Committee. The CanNASH Steering Committee acknowledges that funding by way of an unrestricted educational grant  was provided by Novo Nordisk.

Title: A Multidisciplinary Approach to NASH

Moderator: Giada Sebastiani, McGill University

Case 1: patient with type 2 diabetes and fibrosis stage 3

Case 2: patients with obesity, fibrosis stage 2 and previous cardiovascular event/high cardiovascular risk

Speaker:

Kaberi Dasgupta, McGill University.

James Kim, University of Calgary

Date and Time: Friday, March 3  12:15 - 13:00

Location: Room 612/613

Saturday, March 4

7:30 - 8:30 CDDW™ INDUSTRY BREAKFAST SYMPOSIUM

Presented by

Title: Practical Clinical Decisions in Crohn’s Disease

Learning Objectives:

Following the program participants will be able to:

  • Identify the patient characteristics that influence treatment choice in CD
  • Evaluate the effectiveness of treatments in CD
  • Determine when treatment should be altered to improve patient outcomes in CD

SpeakerMark Borgaonkar, MD, MSc, FRCPC, FACG, CAGF, Professor of Medicine, Memorial University of Newfoundlan

Date and Time: Saturday, March 4  7:30 - 8:30

Location: Room 501/502

11:45 - 12:45 CLM INDUSTRY LUNCH SYMPOSIUM

Presented by

Title: HCV Right Here & Right Now: Don’t Wait… Now’s the time to Eliminate!

An interactive, solution-based workshop to overcome barriers and enhance the testing and treatment of HCV.

Learning Objectives
• Identify interventions and strategies to simplify HCV testing and linkage to care
• Share good practices to improve engagement with patients and healthcare providers

Speaker & Facilitator:

Professor Jason Grebely, Head of Hepatitis and Drug Use Research Group Viral Hepatitis Clinical Research Program, The Kirby Institute, UNSW Sydney and President, International Network on Health and Hepatitis  in Substance Users (INHSU)

Workshop moderators:

Gisela Macphail, MD, MPH, FRCPC - Infectious Diseases Specialist, CUPS Liver Clinic and Clinical Assistant Professor, Cumming School of Medicine, University of Calgary

Abdel Aziz Shaheen, Assistant Professor, Department of Medicine and Community Health Sciences, University of Calgary

Bernadette Lettner, RN - Toronto Community Hep C program South Riverdale, Toronto ON

Date and Time: Saturday March 4th 11:45 am – 12:45pm

Location: Room 612/613

12:30 - 13:30 CDDW™ INDUSTRY LUNCH SYMPOSIUM

Presented by

Title: IBD MedTalks

Three MEDTalk videos, focusing on informative clinical updates, highlights and trends on the topics of Mucosal Healing, Sexuality and IBD, and Pregnancy and IBD.

Learning Objectives:

  • Reflect on the evolving treatment goals in IBD with a closer look at mucosal healing and histological healing targets in IBD with Dr. Vipul Jairath MEDTalk viewing
  • Consider the comprehensive care in IBD with a focus on sexuality and IBD with Dr. Cynthia Seow MEDTalk viewing
  • Explore the evidence on the safety and efficacy of IBD therapies though a patient pregnancy case presentation with Dr. Yvette Leung MEDTalks viewing.

Speaker:

Dr. Cynthia Seow, MBBS (Hons) MSc FRACP

Date and Time: Saturday, March 4  12:30 - 13:30

Location: Room 501/502

RSVP now to secure your spot in one of the CDDW™-CLM Specialty Programming or Industry Symposia sessions.

*CDDW-CLM Industry Symposia are unaccredited sessions